AbbVie to acquire Botox maker Allergan for $63bn
US drugmaker AbbVie has agreed to buy Allergan, the Irish-domiciled maker of Botox, in a $63bn deal that is the sector’s latest blockbuster transaction driven...
Continue ReadingBharat Biotech to collaborate with Hilleman to develop cholera vaccine
Hilleman Laboratories announced on Wednesday that it will collaborate with Hyderabad-based vaccine maker Bharat Biotech International Limited (BBIL) for further development, manufacture and commercialisation of...
Continue ReadingDuPont, BioMe Oxford to co-develop and bring to market smart capsule to sample gut microbiota
Intestinal microbiome, 3D illustration showing anatomy of human digestive system and enteric bacteria Escherichia coli, E. coli, colonizing jejunum, ileum, other parts of intestine. Gut...
Continue ReadingPfizer opens new biologics clinical manufacturing facility in Massachusetts
Pfizer’s Andover site houses commercial manufacturing and product development functions, with colleagues dedicated to the development and production of high-quality complex biologics and vaccines. With...
Continue ReadingNew Data Show Use of Abbott’s FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes
Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has...
Continue ReadingConsultation on draft guideline on quality requirements for medical devices in combination products
EMA has released a draft guideline on the quality requirements for medical devices in human medicines that include a medical device, known as drug-device combinations,...
Continue ReadingAt $2M, priciest ever medicine treats fatal genetic disease
U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys a baby’s muscle control and kills nearly all of those...
Continue ReadingThermo Fisher Scientific inaugurates new facility in Ahmedabad
The state-of-the art facility in the domestic tariff area (DTA) is part of Thermo Fisher’s clinical trials business and was built to help address the...
Continue ReadingShilpa Medicare gets USFDA nod for cancer treatment injection
Shilpa Medicare said it has received approval from the US health regulator for Irinotecan HCL injection, used for treatment of certain kind of cancers. The company has...
Continue Reading
